BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer

European Journal of Human Genetics

Volumn 7, Issue 7, 1999, Pages 833-836

  Gershoni Baruch, Ruth ^a,b   Dagan, Efrat ^a,b   Fried, Getta ^a   Kepten, Ilana ^a   Robinson, Eliezer ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Bilateral breast cancer; BRCA1; BRCA2; Hereditary breast ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BILATERAL CANCER; BREAST CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; JEW; MAJOR CLINICAL STUDY; MUTATION RATE; ONCOGENE; ONSET AGE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; FOUNDER EFFECT; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JEWS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS;

EID: 0032744880     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5200371     Document Type: Article

References (15)

1. Donovan AJ: Bilateral breast cancer. Surg Clin North Am 1990; 70: 1141-1149.
2. Adami HO, Bergstrom R, Hansen J: Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer 1985; 55: 643-647.
3. Neuhausen S, Gilweski T, Norton L et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 1996; 13: 126-128.
4. Offit K, Gilweski T, McGuire P et al. Germline BRCA1 185delAG mutation in Jewish women with breast cancer. Lancet 1996; 347: 1639-1943.
5. Oddoux C, Struewing JP, Clayton CM et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 1996; 14: 188-190.
6. Roa BB, Boyd AA, Volcik K, Richards CS: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996; 14: 185-187.
7. Bruchim Bar Sade R, Theodor L et al: Could the 185delAG BRCA1 be an ancient Jewish mutation? Eur J Hum Genet 1997; 5: 413-416.
8. Abeliovich D, Kaduri L, Lerer I et al. The founder mutations 185delAG and 5382insC in BRCA1 6174delT in BRCA2 appear in 605 of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi Women. Am J Hum Genet 1997; 60: 501-514.
9. Rohlfs EM, Learning WG, Friedman KJ, Couch FJ, Weber BL, Silverman LM: Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. Clin Chem 1997; 43: 24-29.
10. Dawson PJ, Maloney T, Gimotty P, Juneau P, Ownby H. Wolman SR: Bilateral breast cancer: one disease or two? Breast Cancer Res Treat 1991; 19: 233-244.
11. Robinson E, Rennert G, Bar-Deroma R, Dori DL, Neugut AI: The pattern of diagnosis of the second primary tumor in the breast. Breast Cancer Res Treat 1993; 25: 211-215.
12. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA: BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 1996; 334: 137-142.
13. FitzGerald MG, MacDonald DJ, Krainer M et al. Germline BRCA1 mutation in Jewish and non-Jewish women with early onset breast cancer. N Engl J Med 1996; 334: 143-149.
14. Krainer M, Silva-Arrieta S, FitzGerald MG et al. Differential contribution of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med 1997; 336: 1416-1421.
15. Couch FJ, DeShano ML, Blackwood MA et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336: 1409-1415.